Sabra Health Care REIT Inc (SBRA) Given Hold Rating at Canaccord Genuity

Sabra Health Care REIT Inc (NASDAQ:SBRA)‘s stock had its “hold” rating reaffirmed by equities research analysts at Canaccord Genuity in a research note issued on Tuesday, May 9th. They presently have a $26.00 price target on the real estate investment trust’s stock. Canaccord Genuity’s price objective suggests a potential upside of 8.06% from the stock’s previous close.

The analysts wrote, “We expect management’s strong SNF expertise to be instrumental in navigating the balance between rent adjustments, dispositions and operator transitions to improve SNF lease metrics while preserving deal accretion, and in the near term, valuation upside may await greater clarity on these key integration strategies.””

Several other research firms have also weighed in on SBRA. Zacks Investment Research lowered shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Tuesday, April 11th. Cantor Fitzgerald increased their price target on shares of Sabra Health Care REIT from $25.00 to $30.00 and gave the company an “overweight” rating in a research report on Tuesday, February 28th. Mizuho reaffirmed a “neutral” rating and set a $28.00 price objective (up from $22.00) on shares of Sabra Health Care REIT in a report on Monday, February 27th. Stifel Nicolaus upped their price objective on shares of Sabra Health Care REIT from $24.00 to $26.00 and gave the company a “hold” rating in a report on Monday, February 27th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $25.00 price objective on shares of Sabra Health Care REIT in a report on Tuesday, January 31st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $27.38.

Analyst Recommendations for Sabra Health Care REIT (NASDAQ:SBRA)

Sabra Health Care REIT (NASDAQ:SBRA) traded up 0.08% on Tuesday, reaching $24.08. 1,169,794 shares of the company’s stock were exchanged. Sabra Health Care REIT has a 12 month low of $19.30 and a 12 month high of $29.10. The firm has a market cap of $1.58 billion, a PE ratio of 16.64 and a beta of 1.10. The firm’s 50-day moving average is $26.96 and its 200-day moving average is $25.21.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Monday, May 8th. The real estate investment trust reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by $0.33. The company had revenue of $62.65 million for the quarter, compared to the consensus estimate of $63.47 million. Sabra Health Care REIT had a net margin of 27.18% and a return on equity of 7.05%. Sabra Health Care REIT’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.54 EPS. On average, equities analysts forecast that Sabra Health Care REIT will post $1.20 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 31st. Stockholders of record on Thursday, May 18th will be issued a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 7.15%. This is an increase from Sabra Health Care REIT’s previous quarterly dividend of $0.42. The ex-dividend date is Tuesday, May 16th. Sabra Health Care REIT’s dividend payout ratio is presently 178.72%.

TRADEMARK VIOLATION NOTICE: “Sabra Health Care REIT Inc (SBRA) Given Hold Rating at Canaccord Genuity” was reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.chaffeybreeze.com/2017/05/19/sabra-health-care-reits-sbra-hold-rating-reaffirmed-at-canaccord-genuity-updated.html.

Several large investors have recently made changes to their positions in the company. Acrospire Investment Management LLC bought a new stake in shares of Sabra Health Care REIT during the third quarter worth $103,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Sabra Health Care REIT by 14.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares in the last quarter. Bank of Montreal Can increased its stake in shares of Sabra Health Care REIT by 44.1% in the first quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in shares of Sabra Health Care REIT during the fourth quarter worth $120,000. Finally, US Bancorp DE increased its stake in shares of Sabra Health Care REIT by 6.6% in the third quarter. US Bancorp DE now owns 5,508 shares of the real estate investment trust’s stock worth $138,000 after buying an additional 342 shares in the last quarter. 92.07% of the stock is currently owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

5 Day Chart for NASDAQ:SBRA

Receive News & Ratings for Sabra Health Care REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply